Streetbeat News

Products Services

URGN

UroGen Pharma has obtained an exclusive license from medac GmbH to develop a mitomycin-based formulation for the treatment of urothelial cancers. This agreement could potentially enhance UroGen's product portfolio and strengthen its position in the oncology market, specifically targeting treatments for urothelial cancers.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:10 pm

AAPL

Apple Inc. (NASDAQ:AAPL) has updated its App Store policies to allow U.S. developers to use external payment platforms. Developers will pay Apple a 27% fee, reduced from the standard 30%, or 12% for those in the App Store Small Business Program. The policy change follows the Supreme Court's decision not to hear Apple's appeal in the Epic Games case, leading to the end of anti-steering rules. Epic Games' CEO Tim Sweeney criticizes the new policy as 'anticompetitive'.

Portfolio Pulse from Benzinga Neuro

January 17, 2024 | 1:10 pm

MAXN

Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) has launched a new Commercial Partner Program in the U.S. to support solar installers and dealers. The program offers exclusive access to Maxeon's high-efficiency solar modules, a 40-year warranty, sales support, marketing assets, and co-branding opportunities. Maxeon emphasizes its commitment to sustainability and ESG, highlighting its recognition in the Global 100 Index and as a UN Global Compact signatory. Sunterra Solar Inc. has partnered with Maxeon, citing alignment with their sustainable practices and investment strategy. Maxeon is promoting its program at Intersolar North America.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:09 pm

LAZY

Lazydays (NasdaqCM: LAZY) announced a nationwide rebranding campaign, including a new visual identity, digital retail experience, and a stock symbol change to 'GORV' effective January 17, 2024. The rebranding includes new logos, colors, and fonts, and the website will feature a mobile interface and Transparency Mode for detailed pricing. The rebrand aims to make the RV lifestyle more accessible and enhance customer experience.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:08 pm

VTAK

Catheter Precision's VIVO System, a cardiac mapping tool, was featured in a case study published in EP Lab Digest. The case study may increase awareness among medical professionals and potentially boost the adoption of the VIVO System in clinical settings. However, the article does not mention any specific financial data or partnerships that would directly affect stock prices.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:06 pm

FNA

Paragon 28, Inc. (NYSE:FNA) has announced the limited market release of the Bun-Yo-Matic™ Lapidus Clamp System and the completion of its first surgical cases in California and Washington. The Bun-Yo-Matic™ is a unique bunion solution that simulates weight-bearing and allows for compression before hardware application, aiming to provide a more reproducible and efficient foot alignment restoration during Lapidus procedures. The system is compatible with Paragon 28's existing bunion and forefoot solutions, and the company's CEO, Albert DaCosta, anticipates significant growth and improved patient outcomes from this innovation.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:04 pm

EYE

Pair Eyewear, a direct-to-consumer eyewear brand, has announced a partnership with National Vision, Inc. (NASDAQ:EYE), the second-largest optical retailer in the U.S. by sales. This collaboration aims to reimagine the eyewear industry by leveraging Pair Eyewear's customizable eyewear products.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 1:03 pm

AAPL

Apple Inc. (AAPL) is considering reducing iPhone prices in China by up to 500 yuan ($70) due to increased competition. The company may also avoid an import ban on its latest Apple Watch models after a patent dispute with Masimo Corporation. Apple's current dividend yield is 0.52%, with a quarterly dividend of 24 cents per share. To earn $500 a month in dividends, an investor would need to own approximately 6,250 shares, valued at $1,147,688. For a $100 monthly dividend, 1,250 shares or $229,538 would be required. Dividend yields fluctuate with stock price and dividend changes. Apple shares fell 1.2% to close at $183.63 on Tuesday.

Portfolio Pulse from Avi Kapoor

January 17, 2024 | 1:01 pm

ZVSA

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, announced the publication of a peer-reviewed article in Acta Neuropathologica Communications. The article demonstrates that inflammasome activation is linked to an increased risk of brain metastasis in women with Triple-Negative Breast Cancer (TNBC).

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 12:59 pm

TSLA

Tesla, Inc. (NASDAQ:TSLA) shares fell 1.59% in premarket trading to $216.42. The decline follows a period of weakness since mid-July after Q3 results. Factors influencing the drop include weak futures market cues, Tesla's price cuts in Germany, upcoming quarterly results with concerns about margins and 2024 guidance, and weaker-than-expected Q4 GDP data from China, a significant market for Tesla. The stock may remain rangebound until earnings are reported.

Portfolio Pulse from Shanthi Rexaline

January 17, 2024 | 12:51 pm